sa¹ú¼Ê´«Ã½

Health

  • October 28, 2025

    Jushi Sues Doordash, Beverage Sellers Over Hemp Products

    A medical marijuana company owned by cannabis giant Jushi Holdings has sued delivery company DoorDash and beverage industry players, alleging they colluded to sell intoxicating hemp products that mirror marijuana's effects.

  • October 28, 2025

    Greenberg Traurig Guides JV's Outpatient Portfolio Buy

    A Remedy Medical Properties and Kayne Anderson Real Estate joint venture, guided by Greenberg Traurig LLP, has become the top outpatient medical properties owner in the U.S. after it acquired an 18 million-square-foot, 296-property portfolio of outpatient medical facilities from real estate investment trust Welltower. 

  • October 28, 2025

    Curaleaf Asks For Quick Action On NJ Pot Shop Union Rule

    Cannabis giant Curaleaf's ability to operate in New Jersey could be in jeopardy by the end of the week, it told a federal judge Tuesday when seeking an expedited hearing on its motion to block the state's cannabis regulator from requiring the company to adopt labor peace agreements with unions.

  • October 28, 2025

    Colo. Appellate Panel Backs Order To Donate Pre-Embryos

    Colorado appellate judges have upheld a state trial court finding that a nonmarried couple must donate their cryogenically preserved pre-embryos that were created before the dissolution of their relationship.

  • October 28, 2025

    Akin Beats Malpractice Claim Over Alleged IP Theft Plot

    A Third Circuit panel on Tuesday refused to revive a malpractice claim against Akin Gump Strauss Hauer & Feld LLP lodged in a lawsuit that accused attorneys of manipulating patent litigation to steal a former Cornell University graduate student's DNA sequencing intellectual property.

  • October 28, 2025

    HHS Can't Yet Yank Sex Ed Grants Over 'Gender Ideology' Info

    An Oregon federal judge has halted the U.S. Department of Health and Human Services' plans to revoke federal funding for teen sexual health education programs that included "gender ideology," agreeing with states that this is likely a case of executive overreach.

  • October 28, 2025

    4th Circ. Overturns Landmark W.Va. Opioid Verdict

    The Fourth Circuit on Tuesday overturned a key ruling by a West Virginia judge in the first federal bellwether in multidistrict opioid litigation that went in favor of the country's three biggest drug distributors, finding that the oversupply of opioids can create a public nuisance.

  • October 28, 2025

    Ga. Defamation Case Against Atty Hinges On Doctor's Status

    The Georgia Court of Appeals asked a trial court Tuesday to determine whether an orthopedic surgeon in the Peach State is a public figure or private person, a question at the center of whether the physician can pursue a defamation suit against a defense attorney.

  • October 28, 2025

    Wash. Hospital System Can't Undo $230M Wage Suit Loss

    A hospital system can't undo a $230 million judgment against it because it didn't sufficiently counter evidence that its default rounding system was unlawful and assumed caregivers wouldn't take a second meal break, a Washington state appeals panel ruled.

  • October 28, 2025

    Dental Co. Tells Chancery Ex-Executive Stole Business

    A California dental lab sued the former CEO of one of its subsidiaries in the Delaware Chancery Court, saying he violated a multimillion-dollar sale agreement when he resigned, purchased a rival business using information he collected through his former job and is now after its customers.

  • October 28, 2025

    Texas Accuses Tylenol Makers Of Hiding Autism Danger

    The Texas Attorney General's Office on Tuesday sued the makers of Tylenol, alleging they hid the risk that the drug could lead to autism while marketing acetaminophen as the safest pain relief option for pregnant women and young children.

  • October 27, 2025

    Whistleblower 'Horrified' By Novo Nordisk Drug Sales Tactics

    The whistleblower behind a federal lawsuit accusing Novo Nordisk of paying kickbacks to doctors and patients as part of a scheme to drive sales of its hemophilia drug NovoSeven took the witness stand Monday, telling jurors she was "horrified" at how the drugmaker's marketing team targeted doctors.

  • October 27, 2025

    Bros. Had No Fraud Intent In HIV Drug Scam, Fla. Jury Told

    Two Maryland brothers accused of orchestrating a roughly $100 million misbranded HIV drug scheme told a Florida federal jury Monday they had no intent to defraud, saying they were deceived by a co-conspirator who they made a partner in their company. 

  • October 27, 2025

    sa¹ú¼Ê´«Ã½ Says States Can't Enact Medical Debt Reporting Bans

    The Consumer Financial Protection Bureau said Monday that it now believes federal law blocks efforts by states to ban medical debt from credit reports or enact most other credit reporting rules of their own, breaking sharply from its Biden-era stance on the topic.

  • October 27, 2025

    CVS Let 401(k) Get Bogged Down With High Fees, Suit Says

    CVS costs workers millions in retirement savings and violated federal benefits law by failing to rein in excessive administrative fees in its $27 billion 401(k) plan, a former pharmacist said in a proposed class action filed in New York federal court.

  • October 27, 2025

    Acadia Pushes For Appeal Of Investors' Partial Early Win

    Acadia Healthcare Company Inc. is looking to appeal a partial early win granted to a proposed class of investors accusing the company of misleading them about the strength of its United Kingdom operations, arguing that the court's recent ruling presents controlling questions of law warranting immediate appellate review.

  • October 27, 2025

    LifeScan Gets Final OK On Ch. 11 Plan After Deal With PBMs

    A Texas bankruptcy judge on Monday granted confirmation of LifeScan Global Corp.'s Chapter 11 plan after the debtor reached an agreement with pharmacy benefit managers that resolved their objections, allowing the glucose-monitor maker to complete a deal to cut about $1.4 billion of debt.

  • October 27, 2025

    Feds Fight Union Bid To Protect Jobs During Gov't Shutdown

    The Trump administration is fighting a group of unions' request for a California federal judge to block the government from laying off federal workers during the shutdown, saying the injunction request from eight unions is far too broad.

  • October 27, 2025

    AbbVie Defends Challenge Of Colorado's Discount Drug Law

    AbbVie defended its lawsuit challenging a Colorado law it says conflicts with federal law by forcing manufacturers to sell drugs at steep discounts to Walgreens, CVS and other pharmacy chains, telling a federal judge that the state compels the biotech company to sell more discounted drugs than federal law requires.

  • October 27, 2025

    Temp Agency Placed Unqualified Nursing Aides, Charges Say

    A Massachusetts temporary staffing agency sent unqualified nursing aides into at least four healthcare facilities by misrepresenting their credentials, and it allowed one of them to use the identity of a former employee, the state's attorney general alleged in an indictment announced Monday.

  • October 27, 2025

    Colo. Doctor Sues Ex-Employer For Disability Discrimination

    A Colorado emergency physician has filed a discrimination lawsuit against his former employer, alleging the healthcare provider terminated him because of his disability and accommodation requests.

  • October 27, 2025

    Pa. Hospital Workers Seek Initial Approval For OT Suit Deal

    A health system agreed to a $70,000 deal to end a proposed class action alleging it failed to pay unionized hospital workers proper overtime wages, according to an unopposed motion for preliminary approval that the workers filed in Pennsylvania federal court Friday.

  • October 27, 2025

    Judge Tosses Eli Lilly Suit Over Telehealth Weight Loss Drugs

    A California federal court has dismissed a lawsuit from Eli Lilly against a telehealth company and related entities over the compounding of its popular weight loss drugs Mounjaro and Zepbound, saying the pharmaceutical giant's complaint failed to plausibly allege claims under the Lanham Act and the state's false advertising and consumer protection laws.

  • October 27, 2025

    Biotech Firm MapLight Inks $251M IPO Amid Shutdown

    Biotechnology company MapLight Therapeutics began trading publicly Monday after raising $251 million in its initial public offering, which marked a rare listing during the ongoing federal government shutdown.

  • October 27, 2025

    Ex-Magellan CEO Avoids Prison Over Faulty Lead Tests

    The former CEO of Magellan Diagnostics was sentenced in Massachusetts federal court Monday to a year of home confinement for failing to alert regulators to a problem in the company's lead-testing devices that resulted in inaccurately low lead levels being detected in blood samples.

Expert Analysis

  • Mass. Ruling May Pave New Avenue To Target Subpoenas

    Author Photo

    A Massachusetts federal court’s recent decision to quash a subpoena seeking information on gender-affirming care at Boston Children’s Hospital is a significant departure from courts' deferential approach to subpoena enforcement, and may open a new pathway for practitioners challenging investigative tools in the future, say attorneys at Gibson Dunn.

  • What To Expect After FDA Warnings To GLP-1 Compounders

    Author Photo

    The U.S. Food and Drug Administration's recent warning letters to companies advertising compounded versions of GLP-1 medications raise questions not just about the enforcement outlook for marketing such products, but also about the future of drug compounding as a whole, say attorneys at Spencer Fane.

  • Why Justices Seem Inclined To Curtail Del. Affidavit Statute

    Author Photo

    After recent oral argument before the U.S. Supreme Court in Berk v. Choy — asking whether Delaware's affidavit-of-merit statute applies in federal diversity actions, or whether the Federal Rules of Civil Procedure displace the state requirement — it appears the court is poised to simplify the standard approach, says Eric Weitz of The Weitz Law Firm.

  • How Financial Cos. Can Prep As NYDFS Cyber Changes Loom

    Author Photo

    Financial institutions supervised by the New York State Department of Financial Services can prepare for two critical cybersecurity requirements relating to multifactor authentication and asset inventories, effective Nov. 1, by conducting gap analyses and allocating resources to high-risk assets, among other steps, say attorneys at Pillsbury.

  • Series

    Adapting To Private Practice: 3 Tips On Finding The Right Job

    Author Photo

    After 23 years as a state and federal prosecutor, when I contemplated moving to a law firm, practicing solo or going in-house, I found there's a critical first step — deep self-reflection on what you truly want to do and where your strengths lie, says Rachael Jones at McKool Smith.

  • How Courts May Interpret Data-Driven Healthcare Fraud Suits

    Author Photo

    As the U.S. Department of Justice and other agencies increasingly turn to data mining as an enforcement tool, courts will have to determine how far data alone can take a fraud case, and sound theory, clinical expertise and institutional context will play an important role, say Jaime Jones at Sidley and Andrée-Anne Fournier and Atang Gilika at Analysis Group.

  • AG Watch: Va. Race Spotlights Consumer Protection Priorities

    Author Photo

    Ahead of the state's attorney general election, Virginia companies should assess how either candidate's approach could affect their compliance posture, with incumbent Jason Miyares promising a business-friendly atmosphere that prioritizes public safety and challenger Jay Jones pledging to focus on economic justice and corporate accountability, says Chuck Slemp at Cozen O’Connor.

  • Series

    Painting Makes Me A Better Lawyer

    Author Photo

    Painting trains me to see both the fine detail and the whole composition at once, enabling me to identify friction points while keeping sight of a client's bigger vision, but the most significant lesson I've brought to my legal work has been the value of originality, says Jana Gouchev at Gouchev Law.

  • Hybrid Claims In Antitrust Disputes Spark Coverage Battles

    Author Photo

    Antitrust litigation increasingly includes claims for breach of warranty, product liability or state consumer protection violations, complicating insurers' reliance on exclusions as courts analyze whether these are antitrust claims in disguise, says Jameson Pasek at Caldwell Law.

  • Drug Ad Crackdown Demonstrates Admin's Aggressive Stance

    Author Photo

    Recent actions by the U.S. Food and Drug Administration and U.S. Department of Health and Human Services targeting pharmaceutical companies' allegedly deceptive advertising practices signal an active — potentially even punitive — intent to regulate direct-to-consumer advertising out of existence, say attorneys at King & Spalding.

  • Protecting Sensitive Court Filings After Recent Cyber Breach

    Author Photo

    In the wake of a recent cyberattack on federal courts' Case Management/Electronic Case Files system, civil litigants should consider seeking enhanced protections for sensitive materials filed under seal to mitigate the risk of unauthorized exposure, say attorneys at Redgrave.

  • How Gov't Shutdown Will Affect Federal Health Agencies

    Author Photo

    Federal health agencies' contingency plans indicate that many major programs will remain insulated from disruption during the ongoing government shutdown, but significant policy proposals will likely be delayed and the Trump administration's emphasis on reduction-in-force plans distinguishes this shutdown from past lapses, says Miranda Franco at Holland & Knight.

  • Series

    Judging Figure Skating Makes Me A Better Lawyer

    Author Photo

    Judging figure skating competitions helps me hone the focus, decisiveness and ability to process complex real-time information I need in court, but more importantly, it makes me reengage with a community and my identity outside of law, which, paradoxically, always brings me back to work feeling restored, says Megan Raymond at Groombridge Wu.

  • $100K H-1B Fee May Disrupt Rural Healthcare Needs

    Author Photo

    The Trump administration's newly imposed $100,000 supplemental fee on new H-1B petitions may disproportionately affect healthcare employers' ability to recruit international medical graduates, and the fee's national interest exceptions will not adequately solve ensuing problems for healthcare employers or medically underserved areas, say attorneys at Holland & Knight.

  • What Ethics Rules Say On Atty Discipline For Online Speech

    Author Photo

    Though law firms are free to discipline employees for their online commentary about Charlie Kirk or other social media activity, saying crude or insensitive things on the internet generally doesn’t subject attorneys to professional discipline under the Model Rules of Professional Conduct, says Stacie H. Rosenzweig at Halling & Cayo.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.